Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in Eastern Saudi Arabia

Naglaa A. Fawaz; Hala Tamim; Wassim Y. Almawi

doi:10.1016/j.ajic.2004.08.006

Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in Eastern Saudi Arabia

Naglaa A. Fawaz, Hala Tamim, Wassim Y. Almawi^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Abstract

The seroprevalence of human T-lymphotropic virus (HTLV)-I/II was assessed in 13,443 consecutive blood donors in eastern Saudi Arabia between 1998 and 2001. Screening by enzyme-linked immunosorbent assay (ELISA) and confirmation by Western blot resulted in 8 (0.060%) positive cases, of which 5 (0.056%) belonged to Saudi and 3 (0.113%) to non-Saudi donors. The majority of the HTLV-positive donations (6/8) were for patients, and none had a history of known risk factor for HTLV-I/II transmission. Although the very low prevalence of HTLV-I/II among Saudi donors does not support routine screening, screening of donors from other nationalities may be initiated, especially those from HTLV-I/II endemic areas.

Original language	English
Pages (from-to)	189-191
Number of pages	3
Journal	American Journal of Infection Control
Volume	33
Issue number	3
DOIs	https://doi.org/10.1016/j.ajic.2004.08.006
Publication status	Published - Apr 2005
Externally published	Yes

ASJC Scopus subject areas

Epidemiology
Health Policy
Public Health, Environmental and Occupational Health
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ajic.2004.08.006

Cite this

@article{28a3a975a08b4d5598cae08159826ab5,

title = "Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in Eastern Saudi Arabia",

abstract = "The seroprevalence of human T-lymphotropic virus (HTLV)-I/II was assessed in 13,443 consecutive blood donors in eastern Saudi Arabia between 1998 and 2001. Screening by enzyme-linked immunosorbent assay (ELISA) and confirmation by Western blot resulted in 8 (0.060%) positive cases, of which 5 (0.056%) belonged to Saudi and 3 (0.113%) to non-Saudi donors. The majority of the HTLV-positive donations (6/8) were for patients, and none had a history of known risk factor for HTLV-I/II transmission. Although the very low prevalence of HTLV-I/II among Saudi donors does not support routine screening, screening of donors from other nationalities may be initiated, especially those from HTLV-I/II endemic areas.",

author = "Fawaz, {Naglaa A.} and Hala Tamim and Almawi, {Wassim Y.}",

year = "2005",

month = apr,

doi = "10.1016/j.ajic.2004.08.006",

language = "English",

volume = "33",

pages = "189--191",

journal = "American Journal of Infection Control",

issn = "0196-6553",

publisher = "Mosby Inc.",

number = "3",

}

TY - JOUR

T1 - Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in Eastern Saudi Arabia

AU - Fawaz, Naglaa A.

AU - Tamim, Hala

AU - Almawi, Wassim Y.

PY - 2005/4

Y1 - 2005/4

N2 - The seroprevalence of human T-lymphotropic virus (HTLV)-I/II was assessed in 13,443 consecutive blood donors in eastern Saudi Arabia between 1998 and 2001. Screening by enzyme-linked immunosorbent assay (ELISA) and confirmation by Western blot resulted in 8 (0.060%) positive cases, of which 5 (0.056%) belonged to Saudi and 3 (0.113%) to non-Saudi donors. The majority of the HTLV-positive donations (6/8) were for patients, and none had a history of known risk factor for HTLV-I/II transmission. Although the very low prevalence of HTLV-I/II among Saudi donors does not support routine screening, screening of donors from other nationalities may be initiated, especially those from HTLV-I/II endemic areas.

AB - The seroprevalence of human T-lymphotropic virus (HTLV)-I/II was assessed in 13,443 consecutive blood donors in eastern Saudi Arabia between 1998 and 2001. Screening by enzyme-linked immunosorbent assay (ELISA) and confirmation by Western blot resulted in 8 (0.060%) positive cases, of which 5 (0.056%) belonged to Saudi and 3 (0.113%) to non-Saudi donors. The majority of the HTLV-positive donations (6/8) were for patients, and none had a history of known risk factor for HTLV-I/II transmission. Although the very low prevalence of HTLV-I/II among Saudi donors does not support routine screening, screening of donors from other nationalities may be initiated, especially those from HTLV-I/II endemic areas.

UR - http://www.scopus.com/inward/record.url?scp=15744386944&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15744386944&partnerID=8YFLogxK

U2 - 10.1016/j.ajic.2004.08.006

DO - 10.1016/j.ajic.2004.08.006

M3 - Article

C2 - 15798675

AN - SCOPUS:15744386944

SN - 0196-6553

VL - 33

SP - 189

EP - 191

JO - American Journal of Infection Control

JF - American Journal of Infection Control

IS - 3

ER -

Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in Eastern Saudi Arabia

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this